Earnings Alerts

Petronas Chemicals Group (PCHEM) Earnings: 2Q Results Show 14 Sen Loss Per Share Despite 2.1 Sen EPS Estimate

“`html

  • Petronas Chemicals reported a loss per share of 14 sen for the second quarter.
  • Analysts had estimated earnings per share (EPS) to be 2.1 sen.
  • The company reported a net loss of 1.08 billion ringgit for the quarter.
  • Revenue for the quarter was 6.44 billion ringgit.
  • Investment analysts’ recommendations include 3 buys, 9 holds, and 9 sells.

“`


A look at Petronas Chemicals Group Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth2
Resilience3
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Petronas Chemicals Group Bhd. is poised for a positive long-term outlook. The company received a high score of 4 for Value, indicating that it is considered undervalued relative to its fundamentals. This suggests potential for capital appreciation over time. In terms of Dividend and Resilience, the company scored 3, reflecting a solid performance in these areas. This indicates that investors can expect a stable dividend yield and that the company has demonstrated resilience in the face of market challenges.

However, Petronas Chemicals Group scored lower in the areas of Growth and Momentum, with scores of 2 and 4 respectively. This suggests that while the company may face challenges in terms of growth opportunities, its overall momentum is still positive. In summary, Petronas Chemicals Group Bhd., a chemical company offering a diversified range of products, presents an intriguing long-term investment opportunity with its strong value proposition, stable dividend performance, and resilient nature.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars